tradingkey.logo
tradingkey.logo
検索

Elanco Animal Health Inc

ELAN
ウォッチリストに追加
26.370USD
-0.070-0.26%
終値 07-31 16:00ET15分遅れの株価
13.17B時価総額
損失額直近12ヶ月PER

詳細情報 Elanco Animal Health Inc 企業名

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.

Elanco Animal Health Incの企業情報

企業コードELAN
会社名Elanco Animal Health Inc
上場日Sep 20, 2018
最高経営責任者「CEO」Simmons (Jeffrey N)
従業員数9000
証券種類Ordinary Share
決算期末Sep 20
本社所在地450 Elanco Circle
都市INDIANAPOLIS
証券取引所NASDAQ OMX NASDAQ Basic NYSE
United States of America
郵便番号46221
電話番号18773526261
ウェブサイトhttps://www.elanco.com/
企業コードELAN
上場日Sep 20, 2018
最高経営責任者「CEO」Simmons (Jeffrey N)

Elanco Animal Health Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
101.69K
+16.59%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
94.39K
+4.96%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
83.83K
+35.69%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
71.18K
+12.12%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%

よくある質問

Elanco Animal Health Incの上位5名の株主は誰ですか?

Elanco Animal Health Incの上位5名の株主は以下のとおりです。Mr. Jeffrey N. (Jeff) Simmons

Elanco Animal Health Inc(ELAN)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Elanco Animal Health Incの株式を保有している機関は950社あり、保有株式の総市場価値は約549.30Mで、全体の109.98%を占めています。2025Q4と比較して、機関の持ち株は-60070109.00増加しています。

Elanco Animal Health Incの最大の収益源は何ですか?

2026Q1において、Farm Animal部門がElanco Animal Health Incにとって最大の収益を生み出しており、その金額は2.36Bで、全収益の50.10%を占めています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。